UC Berkeley, UCSF scientists find diverse CRISPR gene editors in viruses
Researchers at UC Berkeley and UCSF’s Innovative Genomics Institute, or IGI, have found the diversity of CRISPR gene editors in viruses goes far beyond what they expected, possibly leading to new ways of editing genomes.
UC Berkeley, UCSF scientists find diverse CRISPR gene editors in viruses
Researchers at UC Berkeley and UCSF’s Innovative Genomics Institute, or IGI, have found the diversity of CRISPR gene editors in viruses goes far beyond what they expected, possibly leading to new ways of editing genomes.
FDA approves CRISPR gene therapy trials for sickle cell disease
CRISPR genome editing technology, which was developed at UC Berkeley, has been approved for clinical trials to correct gene mutations responsible for sickle cell disease.
FDA approves CRISPR gene therapy trials for sickle cell disease
CRISPR genome editing technology, which was developed at UC Berkeley, has been approved for clinical trials to correct gene mutations responsible for sickle cell disease.
Campus researchers sequence coronavirus genome, find several strains
Amid a surge in COVID-19 cases and the detection of new variants of the virus on campus, the Innovative Genomics Institute, or IGI, at UC Berkeley aims to sequence viral genomes to improve student safety.
Campus researchers sequence coronavirus genome, find several strains
Amid a surge in COVID-19 cases and the detection of new variants of the virus on campus, the Innovative Genomics Institute, or IGI, at UC Berkeley aims to sequence viral genomes to improve student safety.
UC Berkeley institute to end COVID-19 saliva test trial
UC Berkeley's Innovative Genomics Institute, or IGI's, Free Asymptomatic Saliva Test, or FAST, study for COVID-19 will end Thursday after having tested more than 4,800 people, according Jennifer Doudna, president and chair of the IGI governance board
UC Berkeley institute to end COVID-19 saliva test trial
UC Berkeley's Innovative Genomics Institute, or IGI's, Free Asymptomatic Saliva Test, or FAST, study for COVID-19 will end Thursday after having tested more than 4,800 people, according Jennifer Doudna, president and chair of the IGI governance board
UC Berkeley professor Jennifer Doudna receives Nobel Prize in chemistry
Jennifer Doudna, UC Berkeley professor of chemistry, biochemistry and molecular biology, was awarded half of the Nobel Prize in chemistry Wednesday for developing the gene-editing technology CRISPR-Cas9.
UC Berkeley professor Jennifer Doudna receives Nobel Prize in chemistry
Jennifer Doudna, UC Berkeley professor of chemistry, biochemistry and molecular biology, was awarded half of the Nobel Prize in chemistry Wednesday for developing the gene-editing technology CRISPR-Cas9.